Home › Funds › Lingotto Investment Management LLP › MRNA

Lingotto Investment Management LLP position in MRNA

MODERNA INC · Health Care

Lingotto Investment Management LLP reported holding 749,208 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$144.3M, representing 2.60% of its reported portfolio and ranking #12 among its reported holdings. Lingotto Investment Management LLP has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)749.21K sh
Reported value held$144.27M
Portfolio Weight2.60%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Lingotto Investment Management LLP's MRNA position evolved

Lingotto Investment Management LLP first disclosed a stake in MRNA in Q3 2023 at 133,095 shares (US$13.7M). The position peaked in Q3 2026 at 749,208 shares, worth US$144.3M. Across 13 filings, Lingotto Investment Management LLP increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 749,208 shares valued at US$144.3M — a reduction of -14,699 shares quarter over quarter.. Notable position changes include a 75% increase in Q4 2023 (shares rose 7% over the following quarter), a 34% increase in Q4 2025 (shares rose 72% over the following quarter), a 53% increase in Q1 2026 (shares rose 38% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 133.09K $13.75M New
Q4 2023 233.09K $23.18M Add
Q1 2024 303.10K $32.30M Add
Q2 2024 348.10K $41.34M Add
Q3 2024 373.10K $24.93M Add
Q4 2024 373.10K $15.51M Hold
Q1 2025 373.10K $10.58M Hold
Q2 2025 373.10K $10.29M Hold
Q3 2025 373.10K $9.64M Hold
Q4 2025 498.69K $14.71M Add
Q1 2026 763.91K $38.81M Add
Q2 2026 763.91K $53.50M Hold
Q3 2026 749.21K $144.27M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 41 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has Lingotto Investment Management LLP held MRNA?

Lingotto Investment Management LLP has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Lingotto Investment Management LLP's current position in MRNA?

As of Q3 2026, Lingotto Investment Management LLP holds 749.21K shares of MRNA (MODERNA INC), valued at $144.27M, representing 2.60% of its reported portfolio and ranking #12.

Has Lingotto Investment Management LLP been buying or selling MRNA?

In the latest 13F filing (Q3 2026), Lingotto Investment Management LLP reduced its position in MRNA. The position peaked in Q3 2026 at 749.21K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.